Literature DB >> 15620660

Significant role for p16INK4a in p53-independent telomere-directed senescence.

Jacqueline J L Jacobs1, Titia de Lange.   

Abstract

Telomere attrition in primary human fibroblasts induces replicative senescence accompanied by activation of the p53 and p16(INK4a)/RB tumor suppressor pathways. Although the contribution of p53 and its target, p21, to telomere-driven senescence have been well established, the role of p16(INK4a) is controversial. Attempts to dissect the significance of p16(INK4a) in response to telomere shortening have been hampered by the concomitant induction of p16(INK4a) by cell culture conditions. To circumvent this problem, we studied the role of p16(INK4a) in the cellular response to acute telomere damage induced by a dominant negative allele of TRF2, TRF2(Delta B Delta M). This approach avoids the confounding aspects of culture stress because parallel cultures with and without telomere damage can be compared. Telomere damage generated with TRF2(Delta B Delta M) resulted in induction of p16(INK4a) in the majority of cells as detected by immunohistochemistry. Inhibition of p16(INK4a) with shRNA or overexpression of BMI1 had a significant effect on the telomere damage response in p53-deficient cells. While p53 deficiency alone only partially abrogated the telomere damage-induced cell cycle arrest, combined inhibition of p16(INK4a) and p53 led to nearly complete bypass of telomere-directed senescence. We conclude that p16(INK4a) contributes to the p53-independent response to telomere damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15620660     DOI: 10.1016/j.cub.2004.12.025

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  69 in total

1.  Aging of the subventricular zone neural stem cell niche.

Authors:  Joanne C Conover; Brett A Shook
Journal:  Aging Dis       Date:  2011-09-20       Impact factor: 6.745

2.  Co-regulation of p16INK4A and migratory genes in culture conditions that lead to premature senescence in human keratinocytes.

Authors:  Benjamin W Darbro; Galen B Schneider; Aloysius J Klingelhutz
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

3.  p53 mediates senescence-like arrest induced by chronic replicational stress.

Authors:  Andriy Marusyk; Linda J Wheeler; Christopher K Mathews; James DeGregori
Journal:  Mol Cell Biol       Date:  2007-05-21       Impact factor: 4.272

Review 4.  Fusing telomeres with RNF8.

Authors:  Jacqueline J L Jacobs
Journal:  Nucleus       Date:  2012-03-01       Impact factor: 4.197

5.  Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia.

Authors:  James H Upton; Rosalind F Hannen; Adiam W Bahta; Nilofer Farjo; Bessam Farjo; Michael P Philpott
Journal:  J Invest Dermatol       Date:  2015-02-03       Impact factor: 8.551

Review 6.  Telomere dysfunction and tumour suppression: the senescence connection.

Authors:  Yibin Deng; Suzanne S Chan; Sandy Chang
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

7.  JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence.

Authors:  Koji Nakade; Jianzhi Pan; Takahito Yamasaki; Takehide Murata; Bohdan Wasylyk; Kazunari K Yokoyama
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

8.  Geroconversion of aged muscle stem cells under regenerative pressure.

Authors:  Pedro Sousa-Victor; Eusebio Perdiguero; Pura Muñoz-Cánoves
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.

Authors:  Yang Wang; Norman Sharpless; Sandy Chang
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 10.  Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease.

Authors:  Anthony J Donato; Daniel R Machin; Lisa A Lesniewski
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.